Gene · 3745
Papers1,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The sodium-glucose cotransporter 2 inhibitor tofogliflozin induces vasodilation of rabbit femoral artery by activating Kv channels, the SERCA pump, and the sGC/cGMP pathway. | Eur J Pharmacol | 2025 | 40189081 | PubTator, text mining | PubMed |
| Glabridin as a selective Kv2.1 inhibitor ameliorates DPN pathology by disrupting the Aβ/Kv2.1/JNK/NF-κB/NLRP3/p-Tau pathway. | Acta Pharmacol Sin | 2025 | 40113986 | PubTator, text mining | PubMed |
| Drofenine as a Kv2.1 inhibitor alleviated AD-like pathology in mice through Aβ/Kv2.1/microglial NLRP3/neuronal Tau axis. | Acta Pharm Sin B | 2025 | 40041886 | PubTator, text mining | PubMed |
| Beneficial effects of Lactiplantibacillus plantarum BGPKM22 manifest only in interaction with healthy, but not with diseased human bronchial epithelial cells. | Benef Microbes | 2025 | 39970930 | PubTator, text mining | PubMed |
| Functions and clinical significance of KCNB1 in esophageal squamous cell carcinoma. | J Gastroenterol | 2025 | 39893596 | PubTator, text mining | PubMed |
| The Shab family potassium channels are highly enriched at the presynaptic terminals of human neurons. | J Biol Chem | 2025 | 39880095 | PubTator, text mining | PubMed |
| Activation of the Voltage-Gated Potassium Channel by Amphiphilic Glycopeptides. | Chemistry | 2025 | 39836913 | PubTator, text mining | PubMed |
| De novo KCNB1 missense variant causing developmental and epileptic encephalopathy: Two case reports. | Medicine (Baltimore) | 2025 | 39792727 | PubTator, text mining | PubMed |
| Blockade of Voltage-Gated K+ Channels in Rabbit Coronary Arterial Smooth Muscle Cells by the Antipsychotic Drug Zotepine. | J Appl Toxicol | 2025 | 39653067 | PubTator, text mining | PubMed |
| Intravenous anesthetics have differential effects on human potassium channels. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 40384046 | PubTator, text mining | PubMed |
| Hypoxic Pulmonary Vasoconstriction: An Important Component of the Homeostatic Oxygen Sensing System. | Physiol Res | 2024 | 39589299 | PubTator, text mining | PubMed |
| A novel loss-of-function KCNB1 gene variant in a twin with global developmental delay and seizures. | Front Cell Neurosci | 2024 | 39469306 | Swiss-Prot, curated | PubMed |
| KCNB1-Leptin receptor complexes couple electric and endocrine function in the melanocortin neurons of the hypothalamus. | FASEB J | 2024 | 39436109 | PubTator, text mining | PubMed |
| [Clinical features of KCNB1 gene variation related developmental and epileptic encephalopathy]. | Zhonghua Er Ke Za Zhi | 2024 | 39429078 | PubTator, text mining | PubMed |
| Distinct mechanisms of inhibition of Kv2 potassium channels by tetraethylammonium and RY785. | bioRxiv | 2024 | 39372771 | PubTator, text mining | PubMed |
| Glucocorticoids Rapidly Modulate CaV1.2-Mediated Calcium Signals through Kv2.1 Channel Clusters in Hippocampal Neurons. | J Neurosci | 2024 | 39299804 | PubTator, text mining | PubMed |
| Weisheng-tang protects against ischemic brain injury by modulating microglia activation through the P2Y12 receptor. | Front Pharmacol | 2024 | 39295932 | PubTator, text mining | PubMed |
| KCNG4 Genetic Variant Linked to Migraine Prevents Expression of KCNB1. | Int J Mol Sci | 2024 | 39201645 | PubTator, text mining | PubMed |
| A novel autism-associated KCNB1 mutation dramatically slows Kv2.1 potassium channel activation, deactivation and inactivation. | Front Cell Neurosci | 2024 | 39135902 | PubTator, text mining | PubMed |
| ω-Grammotoxin-SIA inhibits voltage-gated Na+ channel currents. | J Gen Physiol | 2024 | 39042091 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3745/papers?page=3